After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NEO belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. The current market capitalization of Neogenomics Inc is $1.35B. A total of 2.99 million shares were traded on the day, compared to an average of 3.44M shares.
In the most recent transaction, ALICIA OLIVO bought 4,918 shares of NEO for 9.97 per share on Oct 16 ’25. In a previous transaction on Aug 06 ’25, Sherman Jeffrey Scott bought 20,000 shares at 5.62 per share. NEO shares that Chief Financial Officer owns now total 188,332.
Among the insiders who bought shares, Zook Anthony P. acquired of 17,900 shares on Aug 06 ’25 at a per-share price of $5.58. This resulted in the Chief Executive Officer holding 38,066 shares of NEO after the transaction. In another insider transaction, Kelly Michael Aaron bought 5,000 shares at $7.60 per share on May 27 ’25. Company shares held by the Director now total 5,000.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NEO has a high of $19.11 and a low of $4.72.
As of this writing, NEO has an earnings estimate of $0.04 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of $0.06 per share and a lower estimate of $0.01. The company reported an EPS of $0.04 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NEO’s latest balance sheet shows that the firm has $515.39M in Cash & Short Term Investments as of fiscal 2021. There were $612.79M in debt and $87.23M in liabilities at the time. Its Book Value Per Share was $6.50, while its Total Shareholder’s Equity was $1.11B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NEO is Buy with a score of 3.73.
